Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversidad del Desarrollo

About this trial

The goal of this clinical trial is to test the efficacy of laser photobiomodulation in adult hematologic cancer patients undergoing hematopoietic stem cell transplantation (HSCT). The main questions it aims to answer are: • Is photobiomodulation with laser in the oral cavity, compared to standard care, effective in preventing oral mucositis and functional impairments in adult patients receiving HSCT? • What is the level of patient´s acceptability of photobiomodulation with laser in the oral cavity during HSCT? Participants once a day will receive photobiomodulation (diode laser device) in their oral cavity from the first day of transplantation conditioning until third day post-transplant. Researchers will compare with usual care to see if photobiomodulation helps preventing oral mucositis and functional impairment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults over 18 years of age with hematological neoplasms who require medical indication of an HSCT according to the Transplant Committee at Clinica Dávila

With sufficient understanding of Spanish.

Disqualifiers

Observed cognitive deficit

Patients who do not meet the criteria of clinical stability, progression of the disease, and that do not fulfill requirement of the National Hematopoietic Stem Cell Transplantation Program.

Participants with an oral infection from any type of Candida prior to HSCT.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Photobiomodulation

    Device

    Photobiomodulation will be used in sessions of approximately 5 to 10 minutes each. An InGaIP diode laser will be used with the following parameters: wavelength of 660 nm, output power of 40 mW, and an energy density of 4 J/cm2 measured at the end of the fiber optic with 0.04 cm2 of section area. The laser will be applied at 10 points in each oral region, with an exposure time of 4 s per point, using 0.16 J of energy per point. The protocol was based on previous studies.

  • Usual care

    Other intervention

    Usual care for oral mucositis includes education, cryotherapy, and mouth hygiene.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Photobiomodulation groupExperimental treatment 2 interventions
Group B: Control groupOther 1 intervention

Trial outcomes

Primary outcomes

1

Oral Mucositis

It refers to the maximal degree of oral mucositis developed after stem cell transplantation. It will be recorded daily from the first day after stem cell transplantation up to the day 20 after transplantation). The World Health Organization (WHO) oral mucositis scale will be used. Scores range from 0 (no mucositis), 1 (pain/erythema), 2 (erythema, ulcers; can eat solid foods), 3 (ulceration, requiring only a liquid diet), to 4 (oral feeding is not possible). The higher the grade, the worse the mucositis.

Time frame
From the first day up to the 20th after stem cell transplantation (or up to the day of hospital discharge if prior to day 20)
2

Level of Pain

It refers to the perceived level of pain related to oral mucositis from a numeric scale (0 to 10), where 0 means "no pain" and 10 "the worse possible pain". Higher scores means more pain.

Time frame
From the first day up to the 20th day after stem cell transplantation (or up to the day of hospital discharge if prior to day 20)

Secondary outcomes

1

Handgrip strength

It is the maximal isometric strength of the handgrip that will be measured in KgF with Hydraulic Hand Dynamometer (Jamar Digital Plus®).

Time frame
Through study completion on the day of hospital discharge, an average of 1 month
2

Exercise tolerance

The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an EXERCISE TEST. It will be assessed with the 2-Minute Walking Test is a functional test that assesses an individual's aerobic capacity and is used as a performance measure.

Time frame
Through study completion on the day of hospital discharge, an average of 1 month
3

Physical fitness

It is the ability to carry out daily tasks and perform physical activities in a highly functional state, often as a result of physical conditioning. Physical fitness will be evaluated with the 30-Second Sit and Stand (SST30') assesses the ability to rise from a chair and sit back down, as well as the strength and functionality of the lower limbs.

Time frame
Through study completion on the day of hospital discharge, an average of 1 month
4

Health related quality of life

Health related quality of life is a generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. Quality of life will be assessed using the validated and widely used instrument in the oncology population undergoing hematopoietic stem cell transplantation, the Functional Assessment of Cancer Therapy-Bone Marrow Transplant questionnaire.

Time frame
Through study completion on the day of hospital discharge, an average of 1 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Universidad del Desarrollo

Lead sponsor

Agencia Nacional de Investigación y Desarrollo

Collaborator

Clínica Dávila

Collaborator